Burosumab-twza Subcutaneous and Diethylpropion Controlled-Release Tablets
Determining the interaction of Burosumab-twza Subcutaneous and Diethylpropion Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: diethylpropion
Brand name: Tenuate, Tenuate Dospan
Synonyms: Diethylpropion
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Diethylpropion Extended Release
- Burosumab-twza Subcutaneous-Diethylpropion Hydrochloride
- Burosumab-twza Subcutaneous-Diethylpropion Tablets
- Burosumab-twza Subcutaneous-Difenoxin and Atropine
- Burosumab-twza Subcutaneous-Differin
- Burosumab-twza Subcutaneous-Differin (Adapalene)
- Diethylpropion Controlled-Release Tablets-Buspar
- Diethylpropion Controlled-Release Tablets-Buspar Dividose
- Diethylpropion Controlled-Release Tablets-Buspirone
- Diethylpropion Controlled-Release Tablets-Buspirone Hydrochloride
- Diethylpropion Controlled-Release Tablets-Busulfan
- Diethylpropion Controlled-Release Tablets-Busulfan Concentrate Injection